E7 genetically engineered human cervical cancer autologous cell therapy (Shanghai Tumor Hospital)
E7基因工程人宫颈癌自体细胞治疗（复旦大学附属肿瘤医院）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameE7 genetically engineered human cervical cancer autologous cell therapy (Shanghai Tumor Hospital)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesFudan University Shanghai Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesFudan University Shanghai Cancer Center
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A